Enantioselective Synthesis of PPAR (Peroxisome Proliferator-Activated Receptors) Agonists and Antagonists

ISSN: 1873-5294 (Online)
ISSN: 1568-0266 (Print)

Volume 17, 32 Issues, 2017

Download PDF Flyer

Current Topics in Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 21st of 59 in Chemistry, Medicinal

Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.9
5 - Year: 2.998

Enantioselective Synthesis of PPAR (Peroxisome Proliferator-Activated Receptors) Agonists and Antagonists

Current Topics in Medicinal Chemistry, 14(10): 1283-1293.

Author(s): Pilar Goya, Ruth Perez-Fernandez, Rosario Gonzalez-Muniz and Jose Elguero.

Affiliation: Instituto de Quimica Medica, Juan de la Cierva 3, 28006 Madrid, Spain.


This review deals with stereoselective issues in PPAR ligands some of which are in clinical use for treating certain metabolic disorders. After a short introduction of these nuclear receptor and their agonists, some cases of enantioselective separations are reported. The main part concerns stereoselective synthesis first starting with asymmetric synthesis from chiral precursors followed by what we refer to as “true” enantioselective methods. Some examples are discussed in detail for each particular heading.


PPAR, enantioselective separation, enantioselective synthesis, Evans' chiral auxiliary, asymmetric hydrogenation, chiral HPLC, chiral salts.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 14
Issue Number: 10
First Page: 1283
Last Page: 1293
Page Count: 11
DOI: 10.2174/1568026614666140423112822
Price: $58
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: urooj@benthamscience.org Copyright © 2017 Bentham Science